Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.

Date publication

avril 2018

Journal

Scandinavian journal of gastroenterology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume

Tous les auteurs :
Dignass A, Akbar A, Baumgart DC, Bommelaer G, Bouguen G, Cadiot G, Gillessen A, Grimaud JC, Hart A, Hoque S, Makins R, Michiels C, Moreau J, Premchand P, Ramlow W, Schanz S, Subramanian S, von Tirpitz C, Bonaz B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29513111

Résumé

Current options for patients with steroid-dependent, chronic-active ulcerative colitis (UC) with insufficient response/intolerance to immunosuppressants (ISs) and/or biologics are limited. The aim of this study was to assess the long-term outcome of granulocyte/monocyte adsorptive (GMA) apheresis (Adacolumn) in this population.

Mots clés

Ulcerative colitis, devices, granulocyte/monocyte adsorptive apheresis, inflammatory bowel disease, large intestine

Référence

Scand. J. Gastroenterol.. 2018 04;53(4):442-448